scholarly article | Q13442814 |
P819 | ADS bibcode | 2020NatCo..11.3360B |
P356 | DOI | 10.1038/S41467-020-16991-2 |
P932 | PMC publication ID | 7334216 |
P698 | PubMed publication ID | 32620763 |
P50 | author | Maria Luz Martinez Chantar | Q71860473 |
Devin P Champagne | Q88420139 | ||
Youdinghuan Chen | Q88527808 | ||
Brock C Christensen | Q90721354 | ||
Beatriz Gomez-Santos | Q91022422 | ||
Carmelo García-Monzón | Q95310280 | ||
Mercedes Rincón | Q97069657 | ||
Karen A Fortner | Q100958045 | ||
Lucía Barbier-Torres | Q114293617 | ||
Pablo Fernández-Tussy | Q114293619 | ||
Imanol Zubiete-Franco | Q114293620 | ||
Marta Varela-Rey | Q114293622 | ||
Virginia Gutiérrez-de Juan | Q117263566 | ||
Daniela Mestre | Q117263606 | ||
Juan Anguita | Q40626933 | ||
Teresa C Delgado | Q46754800 | ||
David Fernández-Ramos | Q57023045 | ||
Paula Iruzubieta | Q57414546 | ||
Patricia Aspichueta | Q58112646 | ||
P2093 | author name string | Javier Crespo | |
Águeda González-Rodríguez | |||
Qian Fang | |||
Frederic Tremblay | |||
Dhaval Oza | |||
Emily Giddings | |||
Felipe Valença-Pereira | |||
P2860 | cites work | NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium | Q21144997 |
Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine | Q26992163 | ||
Knocking down disease: a progress report on siRNA therapeutics | Q28082939 | ||
Thyroid hormone induction of mitochondrial activity is coupled to mitophagy via ROS-AMPK-ULK1 signaling | Q28118597 | ||
MCJ/DnaJC15, an endogenous mitochondrial repressor of the respiratory chain that controls metabolic alterations | Q28513253 | ||
A central role for JNK in obesity and insulin resistance | Q29619778 | ||
High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis | Q34023013 | ||
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms | Q34025149 | ||
Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice | Q34376178 | ||
Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective | Q34412650 | ||
Obesity accelerates epigenetic aging of human liver | Q34441968 | ||
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum. | Q34518314 | ||
Safety evaluation of 2'-deoxy-2'-fluoro nucleotides in GalNAc-siRNA conjugates | Q64083092 | ||
Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing | Q86081270 | ||
The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies | Q91110914 | ||
An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema | Q93335756 | ||
Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance | Q34708975 | ||
Proteomic analysis of 4-hydroxynonenal (4-HNE) modified proteins in liver mitochondria from chronic ethanol-fed rats | Q34980950 | ||
Regulation of oxidative stress by methylation-controlled J protein controls macrophage responses to inflammatory insults | Q35078589 | ||
Genetic and epigenetic regulation of gene expression in fetal and adult human livers | Q35302040 | ||
Methylation-controlled J protein promotes c-Jun degradation to prevent ABCB1 transporter expression | Q35856811 | ||
Mitochondrial complex I plays an essential role in human respirasome assembly | Q35868845 | ||
Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. | Q36365999 | ||
Role of mitochondria in non-alcoholic fatty liver disease | Q36849037 | ||
Deficiency of mitochondrial modulator MCJ promotes chemoresistance in breast cancer | Q36956157 | ||
Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease | Q37248725 | ||
JNK at the crossroad of obesity, insulin resistance, and cell stress response. | Q37613827 | ||
Hepatic RNA Interference: Delivery by Synthetic Vectors | Q38200096 | ||
DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery | Q38487123 | ||
Architecture of Human Mitochondrial Respiratory Megacomplex I2III2IV2. | Q38636893 | ||
Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients | Q38668121 | ||
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies | Q38705659 | ||
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma | Q38722204 | ||
Emerging therapies for NASH - the future is now. | Q38748157 | ||
Oxidative stress and lipotoxicity | Q38786583 | ||
Respiratory active mitochondrial supercomplexes. | Q39913363 | ||
Fine-Tuning of CD8(+) T Cell Mitochondrial Metabolism by the Respiratory Chain Repressor MCJ Dictates Protection to Influenza Virus | Q40656271 | ||
The carbon tetrachloride model in mice | Q41121854 | ||
Hypomethylation and hypermethylation of DNA in Wilms tumors. | Q44145932 | ||
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury. | Q47682393 | ||
Current and future pharmacological therapies for NAFLD/NASH. | Q47778507 | ||
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases | Q47779219 | ||
Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity. | Q49830924 | ||
Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates | Q49886926 | ||
Role of Aramchol in steatohepatitis and fibrosis in mice. | Q55135320 | ||
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics | Q57094579 | ||
Mechanisms of NAFLD development and therapeutic strategies. | Q59443140 | ||
P433 | issue | 1 | |
P921 | main subject | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
non-alcoholic fatty liver | Q66299798 | ||
P304 | page(s) | 3360 | |
P577 | publication date | 2020-07-03 | |
P1433 | published in | Nature Communications | Q573880 |
P1476 | title | Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation | |
P478 | volume | 11 |
Search more.